Mitchell Lawrence Jones - 11 Feb 2025 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PALI	Stock Option (Right to Buy)	Award	$0	+29,000		$0.000000	29,000	11 Feb 2025	Common Stock	29,000	$1.13	Direct	F1
transaction	PALI	Restricted Stock Units	Award	$0	+24,000		$0.000000	24,000	11 Feb 2025	Common Stock	24,000		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period with vesting commencing on May 11, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
F2	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F3	The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.